TerminatedNCT02477748

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

Medication studyAges 18–55Israel + United States

The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations: Dothan, United States · Los Alamitos, United States and 35 more locationsSee all locations and recruitment
Activities: Medication described in the protocol · Placebo comparator
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateJune 2015

Recruitment status: Terminated
Enrollment listed in the registry: 283
Sponsor: Alcobra Ltd.
Sponsor type: Other organization
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: United States, Israel
Age range: From 18 Years to 55 Years
Official registry ID: NCT02477748
Official title: Show the full official title
A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Questions about this study?

The HopeStage team will email you.

Recruitment & locations

Terminated

Dothan, United States · Los Alamitos, United States · Newport Beach, United States

34 more locations

San Diego, United States
San Francisco, United States
Colorado Springs, United States
Cromwell, United States
New London, United States
Gainesville, United States
Jacksonville, United States
Orlando, United States
South Miami, United States
Alpharetta, United States
Indianapolis, United States
Lake Charles, United States
Baltimore, United States
Rochester Hills, United States
Saint Charles, United States
Lincoln, United States
Cherry Hill, United States
Princeton, United States
New York, United States
Raleigh, United States
Canton, United States
Oklahoma City, United States
Portland, United States
Media, United States
Charleston, United States
Memphis, United States
Austin, United States
Houston, United States
Salt Lake City, United States
Herndon, United States
Seattle, United States
Middleton, United States
Haifa, Israel
Petah Tikva, Israel

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Alcobra Ltd.

Does this study involve medication?

Yes. The study involves medication, including MDX and Placebo.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me